Neutrophil-to-Lymphocyte Ratio and Pembrolizumab Outcomes in Oral Cavity Squamous Cell Carcinoma. Truong AA, Lee RH, Wu X, Algazi AP, et al. Otolaryngol Head Neck Surg 2025;172:548-555.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Truong AA, Lee RH, Wu X, Algazi AP, et al. Neutrophil-to-Lymphocyte Ratio and Pembrolizumab Outcomes in Oral Cavity Squamous Cell Carcinoma. Otolaryngol Head Neck Surg 2025;172:548-555.
PMID: 39675043